Vertex Pharmaceuticals $VRTX

Health Care · Biotechnology · NASDAQ

S&P 500 Nasdaq-100
Create a scorecard
$546.12
-11.84 (-2.12%)
As of Sep 5, 2026, 8:20 AM EDT
Price history
Loading chart…

Vertex Pharmaceuticals (VRTX) is trading down at $546.12 (-2.12%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

Source: Wikipedia — Vertex Pharmaceuticals

Recent News

No recent news mentioning Vertex Pharmaceuticals in our feed yet.

More Health Care stocks

Browse all companies →